As of June 30, 2026, Argan carries a market capitalization of 1.55B, placing it among publicly traded companies globally. Its enterprise value stands at 3.50B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 1.55B |
| Enterprise Value | 3.50B |
Argan's next confirmed earnings release is scheduled for January 21, 2027.
| Earnings Date | 1/21/2027 |
As of June 30, 2026, Argan has 25.76M shares outstanding.
| Shares Outstanding | 25.76M |
These figures are as of June 30, 2026.
| PB Ratio | 0.63 |
| P/TBV Ratio | 0.64 |
As of June 30, 2026, Argan maintains a current ratio of 0.45, meaning it holds 0.5x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 0.45 |
| Quick Ratio | 0.34 |
| Debt / Equity | 88.49 |
As of the close on October 22, 2026, Argan's stock has declined approximately 1.42% over the past 52 weeks. The 50-day moving average sits at 70.65, while the 200-day moving average is 65.66.
| 52-Week Price Change | -1.42% |
| 50-Day Moving Average | 70.65 |
| 200-Day Moving Average | 65.66 |
As of June 30, 2026, Argan holds 320.47M in cash and equivalents against 2.23B in total debt, resulting in a net debt position of 1.81B. Total book value stands at 2.48B, with working capital of -516.43M providing operational flexibility.
| Cash & Cash Equivalents | 320.47M |
| Total Debt | 2.23B |
| Net Debt | 1.81B |
| Equity (Book Value) | 2.48B |
| Book Value Per Share | 96.12 |
| Working Capital | -516.43M |
Argan's most recent stock split took place on March 23, 2011.
| Last Split Date | 3/23/2011 |
Already premium?